Review on niosomalstructure Through nasal Route
Date
2018
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Journal of Pharmacy and Biological Sciences
Series Info
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS);Volume 13, Issue 1 Ver. V (Jan. – Feb. 2018), PP 29-40
Doi
Scientific Journal Rankings
Abstract
Nanotechnology has created one of the most dynamic science and technology domains at the
confluence of physical sciences, molecular engineering, biology, biotechnology and medicine. There has been a
considerable research interest in the area of developing drug delivery using nanoparticles (NP’s) as carriers for
small and large molecules. Targeting delivery of drugs to the diseased lesions is one of the most important
aspects of drug delivery system especially brain. They have been used in-vivo to protect the drug entity in the
systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and
sustained rate to this site of action. Niosomes are non-ionic surfactant vesicles obtained on hydration of
synthetic nonionic surfactants, with or without incorporation of cholesterol or other lipids. They are vesicular
systems similar to liposomes that can be used as carriers of amphiphilic and lipophilic drugs. Various polymers
have been used in the formulation of niosomes for drug delivery research to increase therapeutic benefit, while
minimizing the side-effects. It is obvious that niosome appears to be a well preferred drug delivery system over
liposome as niosome being stable and economic. Also niosomes have great drug delivery potential for targeted
delivery of anti-cancer, antiinfective agents.Drug delivery potential of niosome can enhance by using novel
concepts like proniosomes, discomes and aspasome.Niosomes represent a promising drug delivery module.
Niosomes are thoughts to be better candidates drug delivery as compared to liposomes due to various factors
like cost, stability etc. Various types of drug deliveries can be possible using niosomes like targeting,
ophthalmic, topical and parenteral.
Description
MSA Google Scholar
Keywords
Nanotechnology, niosomes, nasal route, targeting
Citation
[1] AG seleci,d.,seleci,m.,walter,j. g.,stahl,f.&scheper,T.2016.NiosomesasNanoparticularDrugCarriers:FundamentalsandRecentA pplications.Journal of Nanomaterials,2016. [2] Aggarwal,r.,cardozo,a.&homer,J.2004.Theassessmentoftopicalnasal drug distribution.Clinical Otolaryngology,29, 201-205. [3] AlyautdinR,KhalinI,NafeezaMI,HaronMH,KuznetsovD.Nanoscaledrugdeliverysystemsandtheblood– brainbarrier.IntJNanomedicine.2014;9:795–811 [4] Appasaheb,p.s.,manohar,s.d.,bhanudas,s.r.&anjaneri,N.2013.Areviewonintranasaldrugdeliverysystem.JournalofAdvancedPharmac y Education&Research Oct-Dec, 3. [5] Arora,p.,sharma,s.&garg,S.2002.Permeabilityissuesinnasaldrugdelivery.Drug discovery today, 7, 967-975. [6] Bagheri,A.,Chu,B.S.andYaakob,H.,2014.Niosomaldrugdeliverysystems:formulation,preparationandapplications.WorldApplSciJ, 32(8),pp.1671-1685. [7] Bakke,h.,samdal,h.,holst,j.,oftung,f.,haugen,i.,kristoffersen,a.c.,haugan,a.,janakova,l.,korsvold,g.&krogh,G.2006Oralsprayimmu nizationmaybeanalternativetointranasalvaccinedeliverytoinducesystemicantibodiesbutnotnasalmucosalorcellularimmunity.Scandi navianjournalofimmunology,63,223-231 [8] Bini,k.,akhilesh,d.,prabhakara,p.&jv,k.2012.Developmentandc h a r a c t e r i z a t i o n ofnonionicsurfactantvesicles(niosomes) fo oraldeliveryoflornoxicam.InternationalJournalofDrugDevelopmentandResearch. [9] Bitter,c.,suter-zimmermann,k.&surber,C.2011.Nasaldrugdeliveryin humans.Topical Applications and the Mucosa.Karger Publishers. [10] Chandu, V.P., Arunachalam, A., Jeganath, S., Yamini, K., Tharangini, K. and Chaitanya, G., 2012. Niosomes: a novel drug delivery system. Int J Novel Trends Pharm Sci, 2(1), pp.25-31. [11] Das,K.andRam,A.,2013.Niosomeasanoveldrugdeliverysystemareview.International Journal AppliedPharmacy,1(6), pp.1-7. [12] Djupesland,P.G.2013.Nasaldrugdeliverydevices:characteristicsandperformanceinaclinicalperspective— areview.Drugdeliveryandtranslational research,3, 42-62. [13] Djupesland,p.g.&skretting,A.2012.Nasaldepositionandclearanceinman:comparisonofabidirectionalpowderdeviceandatraditionalli quidspraypump.Journalofaerosolmedicineandpulmonarydrug delivery,25, 280-289. [14] Djupesland,p.g.,skretting,a.,winderen,m.&holand,T.2004.Bidirectionalnasaldeliveryofaerosolscanpreventlungdeposition.Journal of aerosol medicine, 17, 249-259. [15] Fonseca-Santos, B., Gremião, M.P.D. and Chorilli, M., 2015. Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. International journal of nanomedicine, 10, p.4981. [16] Gadhiya, P., Shukla, S., Modi, D. and Bharadia, P., 2012. A Review- Niosomes in Targeted Drug Delivery. International Journal for Pharmaceutical Research Scholars, 2, p.61. [17] Gupta,A.,Arora,A.,Menakshi,A.,Sehgal,A.andSehgal,R.,2012.Nanotechnologyand its applications in drugdelivery: areview. [18] Guterres,S.S.,Alves,M.P.andPohlmann,A.R.,2007.Polymericnanoparticles,nanospheres andnanocapsules,for cutaneousapplications.Drugtarget insights, 2, p.147. [19] Hu,C.andRhodes,D.G.,2000.Erratumto‘Proniosomes:ANovelDrugCarrierPreparation’:[Int.J.Pharm.185(1999)23– 35].Internationaljournalofpharmaceutics,206(1), pp.109-122. [20] Kaur,i.p.,bhandari,r.,bhandari,s.&kakkar,V.2008.Potentialofsolidlipidnanoparticlesinbraintargeting.JournalofControlledRelease,1 27, 97-109. [21] Kaur,I.P.,Garg,A.,Singla,A.K.andAggarwal,D.,2004.Vesicularsystemsinoculardrugdelivery:anoverview.Internationaljournalofph armaceutics,269(1),pp.1- [22] Kumar,G.P.andRajeshwarrao,P.,2011.Nonionicsurfactantvesicularsystemsforeffectivedrugdelivery anoverview.ActaPharmaceuti caSinicaB, 1(4),pp.208-219. [23] Mahale, n., thakkar, p., mali, r., walunj, d. &chaudhari, s. 2012. Niosomes: novel sustained release nonionic stable vesicular systems— an overview. Advances in colloid and interface science, 183, 46-54. [24] Mainardes, R.M. and Gremião, M.P.D., 2012. Nanoencapsulation and Characterization of Zidovudine on Poly (L-lactide) and Poly (L-lactide)—Poly (ethylene glycol)-Blend Nanoparticles. Journal of nanoscience and nanotechnology, 12(11), pp.8513-[25] Majgainya, s., soni, s. &bhat, p. novel approach for nose- to-brain drug delivery bypassing blood brain barrier by pressurized olfactory delivery device. [26] Makeshwar, K.B. and Wasankar, S.R., 2013. Niosome: a Novel Drug Delivery System. Asian journal of pharmaceutical research, 3(1), pp.16-20. [27] Management, C. W. O. G. F. A. S. D. 2008. Guideline for Alzheimer's disease management: final report, State of California, Department of Public Health. [28] Manda, R., Suthakaran, R., Kaya, V., Sreedevi, B. and Hurumathfathima, T., 2014. NIOSOME: AN UNIQUE DRUG DELIVERY SYSTEM. [29] McClements, D.J., 2012. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft matter, 8(6), pp.1719-1729. [30] Mehnert, W. and Mäder, K., 2001. Solid lipid nanoparticles: production, characterization and applications. Advanced drug delivery reviews, 47(2), pp.165-196. [31] MOHANRAJ, V. & CHEN, Y. 2006. Nanoparticles-a review. Tropical Journal of Pharmaceutical Research, 5, 561-573. [32] Odeh,F.,AlJaber,H.andKhater,D.,2014.Nanoflorahownanotechnologyenhancedtheuseofactivephytochemicals.ApplicationofNan otechnologyinDrugDelivery, pp.1-15. [33] Pardridge,W.M.2007.Drugtargetingtothebrain.Pharmaceuticalresearch, 24, 1733-1744. [34] Seleci, m., agseleci, d., joncyzk, r., stahl, f., blume, c. &scheper, T. 2016. Smart multifunctional nanoparticles in nanomedicine. BioNanoMaterials, 17, 33-41. [35] Singh, p., prakash, d., ramesh, b., singh, n. &mani, T. T. 2011. Biodegradable polymeric microspheres as drug carriers; A review. Ind J Nov Drug Del, 3, 70-82. [36] Tangri, P. and Khurana, S., 2011. Niosomes: formulation and evaluation. International Journal, 2229, p.7499. [37] Tavano, l., gentile, l., rossi, c. o. &muzzalupo, r. 2013. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery. Colloids and Surfaces B: Biointerfaces, 110, 281-288. [38] Tegeli, v., thorat, y., chougule, g., shivsharan, u., gajeli,g. &kumbhar, S. 2010. Review on concepts and advances in prodrug technology. International Journal of Drug Formulation & Research, 1, 32-57. [39] Tyagi, S., 2012. Novel Drug Delivery System (NDDS): Niosomes. Journal of Biomedical and Pharmaceutical Research, 1(03). [40] Verma, p., thakur, a., deshmukh, k., jha, a. &verma, S. 2010. Routes of drug administration. International Journal of Pharmaceutical Studies and Research, 1, 54-59. [41] Verma, r. k. &garg, s. 2001. Drug delivery technologies and future directions. Pharmaceutical Technology, 25, 1-14.